Kidney Research and Clinical Practice

Search

Page Path

HOME
Search

Original Articles

Serum cystatin C to creatinine ratio is associated with sarcopenia in non-dialysis-dependent chronic kidney disease: Jung Nam An, Jwa-Kyung Kim, Hyung-Seok Lee, Sung Gyun Kim, Hyung Jik Kim, Young Rim Song; Kidney Res Clin Pract. 2022;41(5):580-590. Published online June 24, 2022; DOI: https://doi.org/10.23876/j.krcp.21.214
Web of Science 9 Cited By 10; Full text PubReader ePub PDF Supplementary Material

Ambulatory blood pressure trajectories and blood pressure variability in kidney transplant recipients: a comparative study against chronic kidney disease patients: Maria Korogiannou, Marieta Theodorakopoulou, Pantelis Sarafidis et al.; Kidney Res Clin Pract. 2022;41(4):482-491. Published online June 22, 2022; DOI: https://doi.org/10.23876/j.krcp.21.250
Web of Science 5 Cited By 5; Full text PubReader ePub PDF Supplementary Material

Identification of osteopontin as a urinary biomarker for autosomal dominant polycystic kidney disease progression: Hyunsuk Kim, Jinmo Sung, Ju Young Bae, Poongyeon Lee, Yun Kyu Oh, Hyunho Kim; Kidney Res Clin Pract. 2022;41(6):730-740. Published online June 20, 2022; DOI: https://doi.org/10.23876/j.krcp.21.303
Web of Science 5 Cited By 6; Full text PubReader ePub PDF

Review Articles

Uremic pruritus: pathophysiology, clinical presentation, and treatments: Mei-Ju Ko, Yu-Sen Peng, Hon-Yen Wu; Kidney Res Clin Pract. 2023;42(1):39-52. Published online May 4, 2022; DOI: https://doi.org/10.23876/j.krcp.21.189
Web of Science 6 Cited By 6; Full text PubReader ePub PDF

Original Articles

Albuminuria, estimated glomerular filtration rate, and traditional predictors for composite cardiovascular and kidney outcome: a population-based cohort study in Korea: Hae Hyuk Jung; Kidney Res Clin Pract. 2022;41(5):567-579. Published online May 4, 2022; DOI: https://doi.org/10.23876/j.krcp.22.005
Web of Science 2 Cited By 5; Full text PubReader ePub PDF Supplementary Material

Review Articles

Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options: Yeshwanter Radhakrishnan, Parikshit Duriseti, Fouad T. Chebib; Kidney Res Clin Pract. 2022;41(4):422-431. Published online March 29, 2022; DOI: https://doi.org/10.23876/j.krcp.21.309
Web of Science 8 Cited By 10; Full text PubReader ePub PDF

Exploring molecular targets in diabetic kidney disease: Sayako Maruno, Tetsuhiro Tanaka, Masaomi Nangaku; Kidney Res Clin Pract. 2022;41(Suppl 2):S33-S45. Published online March 15, 2022; DOI: https://doi.org/10.23876/j.krcp.21.251
Web of Science 13 Cited By 13; Full text PubReader ePub PDF

Application of C5 inhibitors in glomerular diseases in 2021: Alexis Werion, Eric Rondeau; Kidney Res Clin Pract. 2022;41(4):412-421. Published online March 15, 2022; DOI: https://doi.org/10.23876/j.krcp.21.248
Web of Science 11 Cited By 13; Full text PubReader ePub PDF

Peritoneal dialysis adequacy: a paradigm shift: Chang Huei Chen, Isaac Teitelbaum; Kidney Res Clin Pract. 2022;41(2):150-155. Published online March 14, 2022; DOI: https://doi.org/10.23876/j.krcp.21.208
Web of Science 1 Cited By 1; Full text PubReader ePub PDF

Original Articles

Mayo imaging classification is a good predictor of rapid progress among Korean patients with autosomal dominant polycystic kidney disease: results from the KNOW-CKD study: Hayne Cho Park, Yeji Hong, Jeong-Heum Yeon et al.; Kidney Res Clin Pract. 2022;41(4):432-441. Published online March 3, 2022; DOI: https://doi.org/10.23876/j.krcp.21.261
Web of Science 5 Cited By 6; Full text PubReader ePub PDF Supplementary Material

The combined clinical impact of red blood cell distribution width and vascular calcification on cardiovascular events and mortality in patients with endstage kidney disease: Da Won Kim, Munpyo Lee, Kwon Jae Lee et al.; Kidney Res Clin Pract. 2022;41(3):351-362. Published online March 3, 2022; DOI: https://doi.org/10.23876/j.krcp.21.078
Web of Science 2 Cited By 2; Full text PubReader ePub PDF

Humoral response to viral vector COVID-19 vaccine in hemodialysis patients: Niranjan Raja, Arul Rajagopalan, Jegan Arunachalam, Arun Prasath, Rakesh Durai, Manorajan Rajendran; Kidney Res Clin Pract. 2022;41(3):342-350. Published online March 3, 2022; DOI: https://doi.org/10.23876/j.krcp.21.184
Web of Science 7 Cited By 6; Full text PubReader ePub PDF

Elderly kidney transplant recipients have favorable outcomes but increased infection-related mortality: Jeong-Hoon Lim, Ga Young Lee, Yena Jeon et al.; Kidney Res Clin Pract. 2022;41(3):372-383. Published online February 23, 2022; DOI: https://doi.org/10.23876/j.krcp.21.207
Web of Science 8 Cited By 10; Full text PubReader ePub PDF Supplementary Material

Review Articles

Why should we focus on high-volume hemodiafiltration?: Sug-Kyun Shin, Young-Il Jo; Kidney Res Clin Pract. 2022;41(6):670-681. Published online February 22, 2022; DOI: https://doi.org/10.23876/j.krcp.21.268
Cited By 2; Full text PubReader ePub PDF

Original Articles

Parathyroidectomy versus cinacalcet in the treatment of tertiary hyperparathyroidism after kidney transplantation: a retrospective study: Suyun Jung, Hyosang Kim, Hyunwook Kwon et al.; Kidney Res Clin Pract. 2022;41(4):473-481. Published online February 22, 2022; DOI: https://doi.org/10.23876/j.krcp.21.210
Web of Science 4 Cited By 4; Full text PubReader ePub PDF Supplementary Material

Volume 43, No. 2

Kidney Research
and
Clinical Practice

Print ISSN: 2211-9132
Online ISSN: 2211-9140

Impact Factor

3.0

MOST VIEWED MOST CITED

15,031	Validation of operational definitions of mortality in a nationwide hemodialysis population using the Health Insurance Review and Assessment Service databases of Korea
19,943	C4d Puzzle in ABO-incompatible kidney transplantation
8,448	How should we treat acute kidney injury caused by renal congestion?
13,170	Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options
35,288	Uremic pruritus: pathophysiology, clinical presentation, and treatments

Cited By 15	Association between blood pressure and the risk of chronic kidney disease in treatment-naïve hypertensive patients
Cited By 13	Exploring molecular targets in diabetic kidney disease
Cited By 13	Application of C5 inhibitors in glomerular diseases in 2021
Cited By 13	GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
Cited By 11	Prostaglandin E2 receptors as therapeutic targets in renal fibrosis

Editorial Office: #301, (Miseung Bldg.) 23, Apgujenog-ro 30-gil, Gangnam-gu, Seoul 06022, Korea
Tel: +82-2-3486-8736 Fax: +82-2-3486-8737 E-mail: registry@ksn.or.kr

Copyright © 2024 by The Korean Society of Nephrology.